Medicud is a company that develops sustainable medical technologies, including the Dryum device, a single-use incisional negative pressure wound therapy (i-NPWT) system intended to improve surgical healing at lower therapy cost and with a reduced environmental footprint. The company is in a clinical phase, targets suitable patients and healthcare providers, and anticipates market entry in 2027.
Subscribe to see Medicud’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Medicud is a medical technology company headquartered in Italy. Its most recent funding round raised $1.4M in April 2025.
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $1.4M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Medicud? Suggest a correction · Work at Medicud? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.